Studies have shown some patients losing 20% or more of their body weight, which can lead to significant improvements in obesity-related conditions
The Standards of Medical Care in Diabetes, updated annually, includes dedicated sections on incretin-based therapies relevant for understanding tirzepatide pharmacology and clinical application
Studies that used 1 mg/day in oral and intravenous trials did not show meaningfully better outcomes than lower doses, and higher doses were associated with more reports of headache, diarrhea, and gastrointestinal effects
There is no official link between moderately elevated B12 levels and specific symptomatology in most individuals
But it also has a thousand other effects, tissue growth, insulin resistance, raising IGF-1 and the risk of acromegaly